Wu Y, Sun X, Yang J, Fan H, Jin O, Tang L
Eur J Pediatr. 2025; 184(3):228.
PMID: 40045148
DOI: 10.1007/s00431-025-06064-1.
Zollner A, Meyer M, Jukic A, Adolph T, Tilg H
Yale J Biol Med. 2024; 97(4):447-462.
PMID: 39703608
PMC: 11650913.
DOI: 10.59249/PMIE8461.
Stich M, Magalhaes V, Burger F, Garbade S, Jeltsch K, Mohr K
J Med Virol. 2024; 96(12):e70098.
PMID: 39624009
PMC: 11612704.
DOI: 10.1002/jmv.70098.
Sigal A, Neher R, Lessells R
Nat Rev Microbiol. 2024; .
PMID: 39587352
DOI: 10.1038/s41579-024-01125-y.
Camporesi A, Morello R, La Rocca A, Zampino G, Vezzulli F, Munblit D
EClinicalMedicine. 2024; 76:102815.
PMID: 39296584
PMC: 11408803.
DOI: 10.1016/j.eclinm.2024.102815.
Artificial intelligence-aiding lab-on-a-chip workforce designed oral [3.1.0] bi and [4.2.0] tricyclic catalytic interceptors inhibiting multiple SARS-CoV-2 protomers assisted by double-shell deep learning.
Kalasin S, Surareungchai W
RSC Adv. 2024; 14(37):26897-26910.
PMID: 39193274
PMC: 11347926.
DOI: 10.1039/d4ra03965c.
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus.
Debuysschere C, Nekoua M, Alidjinou E, Hober D
Nat Rev Endocrinol. 2024; 20(10):588-599.
PMID: 38890459
DOI: 10.1038/s41574-024-01004-9.
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols.
Baig A, Rosko S, Jaeger B, Gerlach J, Rausch H
Inflammopharmacology. 2024; 32(4):2075-2090.
PMID: 38771409
DOI: 10.1007/s10787-024-01483-2.
Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer's disease.
Sriranjini A, Thapliyal A, Pant K
In Silico Pharmacol. 2024; 12(1):21.
PMID: 38559708
PMC: 10973747.
DOI: 10.1007/s40203-024-00195-3.
Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.
Patarca R, Haseltine W
Int J Mol Sci. 2024; 25(6).
PMID: 38542351
PMC: 10970485.
DOI: 10.3390/ijms25063378.
Pathophysiological, immunological, and inflammatory features of long COVID.
Bohmwald K, Diethelm-Varela B, Rodriguez-Guilarte L, Rivera T, Riedel C, Gonzalez P
Front Immunol. 2024; 15:1341600.
PMID: 38482000
PMC: 10932978.
DOI: 10.3389/fimmu.2024.1341600.
Advances in researches on long coronavirus disease in children: a narrative review.
Zhang J, Kuang T, Liu X
Transl Pediatr. 2024; 13(2):318-328.
PMID: 38455739
PMC: 10915432.
DOI: 10.21037/tp-23-472.
Persisting Gastrointestinal Symptoms in Children with SARS-CoV-2: Temporal Evolution over 18 Months and Possible Role of Lactoferrin.
Mariani F, Rainaldi S, DallAra G, De Rose C, Morello R, Buonsenso D
Children (Basel). 2024; 11(1).
PMID: 38255418
PMC: 10814461.
DOI: 10.3390/children11010105.
Muscle abnormalities worsen after post-exertional malaise in long COVID.
Appelman B, Charlton B, Goulding R, Kerkhoff T, Breedveld E, Noort W
Nat Commun. 2024; 15(1):17.
PMID: 38177128
PMC: 10766651.
DOI: 10.1038/s41467-023-44432-3.
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
Mateu L, Tebe C, Loste C, Santos J, Llados G, Lopez C
Lancet Reg Health Eur. 2023; 33:100724.
PMID: 37954002
PMC: 10636281.
DOI: 10.1016/j.lanepe.2023.100724.
Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study.
Wang L, Davis P, Berger N, Kaelber D, Volkow N, Xu R
Fam Med Community Health. 2023; 11(4).
PMID: 37832975
PMC: 10582888.
DOI: 10.1136/fmch-2023-002456.
Case report: Post-COVID new-onset neurocognitive decline with bilateral mesial-temporal hypometabolism in two previously healthy sisters.
Cocciolillo F, Chieffo D, Giordano A, Arcangeli V, Lazzareschi I, Morello R
Front Pediatr. 2023; 11:1165072.
PMID: 37303754
PMC: 10251436.
DOI: 10.3389/fped.2023.1165072.